Search

Your search keyword '"Spranger, Otto"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Spranger, Otto" Remove constraint Author: "Spranger, Otto"
43 results on '"Spranger, Otto"'

Search Results

1. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

2. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

3. Rhinitis associated with asthma is distinct from rhinitis alone: TARIA‐MeDALL hypothesis

5. Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c

6. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

7. Digital transformation of health and care in airway diseases from research to practice

8. ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice

9. Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie

10. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA GroupA in cooperation with the Austrian ARIA GroupB, the Swiss ARIA GroupC, German Society for Applied Allergology (AEDA)D, German Society for Allergology and Clinical Immunology (DGAKI)E, Society for Pediatric Allergology (GPA)F in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHCG and the European Academy of Allergy and Clinical Immunology (EAACI)H

11. Allergen immunotherapy in the current COVID-19 pandemic - A position paper of the AeDA, ARIA, EAACI, DGAKI and GPA

12. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)

13. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic:Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)

14. ARIA digital anamorphosis:Digital transformation of health and care in airway diseases from research to practice

15. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

16. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H

17. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

18. Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c

19. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA

20. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases: Review

21. Европейский стратегический форум по аллергическим болезням : определение приоритетов научных проблем и финансирования в отношении аллергии и бронхиальной астмы и необходимость трансляционных исследований

22. MOESM1 of Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

23. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

24. Next-generation ARIA care pathways for rhinitis and asthma:a model for multimorbid chronic diseases

25. Smoking and severe persistent asthma

27. Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

28. Smoking and severe persistent asthma

29. Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma

30. Asthma patients are Still Fighting for Breath

31. Smoking and severe persistent asthma

32. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

33. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

34. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

35. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

36. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

37. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

38. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs

40. Use of biologics in allergic and type 2 inflammatory diseases in the current Covid 19 pandemic(a, b, c)

41. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.

42. Allergen-Immuntherapie in der aktuellen Covid-19-Pandemie a, b, c .

43. Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemie a, b, c : Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)D, der Luxemburgischen Gesellschaft für Allergologie und Immunologie (LGAI)E, der Österreichischen Gesellschaft für Pneumologie (ÖGP)F in Kooperation mit der deutschen, österreichischen, und schweizerischen ARIA-GruppeG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H.

Catalog

Books, media, physical & digital resources